Medication

Authors

  • Annette Leibing Université de Montréal

DOI:

https://doi.org/10.47854/IQRO3749

Keywords:

Pharmaceuticals, Life cycle, Biomedicalization, Biocapitalism, Incorporated molecules, Public health

Abstract

This entry offers an overview of a part of the literature on medication as a social object. Medication, often perceived in anthropology as an “exotic” object, has become a pharmaceutical object whose biography focuses on different fields of activity, all of which possess a respective set of values and contextual vectors. The pharmaceutical object is now seen as globalized, that is a central object in the construction of a good life, and an object of power and consumption.

References

Abraham, J. (2010), «Pharmaceuticalization of Society in Context: Theoretical, Empirical and Health Dimensions», Sociology, vol.44, nº4, p.603-622.

Angell, M. (2004), The truth about the drug companies: How they deceive us and what to do about it, New York, Random House.

Applbaum, K. (2009), «"Consumers are Patients!" Shared Decision-making and Treatment Non-compliance as Business Opportunity», Transcultural Psychiatry, numéro thématique, «Psychopharmacology in a globalizing world» (L. Kirmayer et E. Raikhel dir.), vol.46, nº1, p.107-130.

Bell, S.E., et A.E Figert (2012), «Medicalization and pharmaceuticalization at the intersections: Looking backward, sideways and forward», Social Science and Medecine, vol.75, nº5, p.775-783.

Clarke, A.E., L. Mamo, J.R. Fishman, J.K. Shim et J.R. Fosket (2003), «Biomedicalization: technoscientific transformations of health, illness, and U.S. Biomedicine», American Sociological Review, vol.68, p.161-194.

Collin, J. (2015), «On Social Plasticity: The Transformative Power of Pharmaceuticals on Health, Nature and Identity», Sociology of Health & Illness, vol.38, nº1, p.73-89.

Conrad, P. (2005), The Medicalisation of Society, Baltimore, Johns Hopkins University Press.

Dumit, J. (2012), Drugs for Life: How Pharmaceutical Companies Define Our Health, Durham, Duke University Press.

Ecks, S. (2005), «Pharmaceutical Citizenship: Antidepressant Marketing and the Promise of Demarginalization in India», Anthropology and Medicine, vol.12, nº3, p.239-254.

Greene, J.A. (2009), Prescribing by Numbers: Drugs and the Definition of Disease, Baltimore, Johns Hopkins University Press.

Hardon, A. et E. Sanabria (2017), «Fluid drugs: Revisiting the anthropology of pharmaceuticals», Annual Review of Anthropology, nº46, p.117-132.

Healy, D. (2004), Let them eat Prozac: The unhealthy relationship between the pharmaceutical industry and depression, New York, New York University Press.

Leibing, A. (2013), «Embodied molecules: Studying medications in troubled times». Dans N. Adelson, L. Butt et K. Kielmann (dir.), Troubling Natural Categories: Engaging the Medical Anthropology of Margaret Lock, Montréal, McGill Queen's University Press, p.168-188.

Leibing, A. et S. Schicktanz (dir.) (2020), Preventing Dementia? Critical perspectives on a new paradigm of preparing for old age, New York et Oxford (R.-U.), Berghahn.

Lovell, A.M. et S. Aubisson (2008), «"Fuitage pharmaceutique". Usages détournés et reconfigurations d’un médicament de substitution aux opiacés», Drogues, santé et société, vol.7, nº1, p. 297-355. https://doi.org/10.7202/019625ar

Metzl, J.M. (2005), Prozac on the couch: Prescribing gender in the era of wonder drugs, Durham, Duke University Press.

Monnais-Rousselot, L. (2019), Vaccination. Le mythe du refus, Montréal, Presses de l'Université de Montréal.

Petryna, A. et A. Kleinman (2006), «The pharmaceutical nexus». Dans A. Petryna, A. Lakoff et A. Kleinman (dir.), Global Pharmaceuticals: Ethics, Markets, Practices, Durham, Duke University Press, p.1-13.

Rose, N. (2007), «Beyond medicalisation», Lancet, vol.369, p.700-702.

van der Geest, S., S.R. Whyte et A. Hardon (1996), «The anthropology of pharmaceuticals: a biographical approach», Annual Review of Anthropology, vol.25, p.153-178.

Downloads

Published

2020-12-19